Preparing your space
Preparing your space
Conditions & Recovery · Oncology Brothers · September 14, 2026
Welcome to the Oncology Brothers podcast! In this episode, we talked about the most recent developments in the world of myeloproliferative neoplasms (MPNs), including the exciting FDA approvals of ropeginterferon alfa-2b for essential thrombocythemia (ET) and rusfertide for polycythemia vera (PV). The leading author Dr. John Mascarenhas, an MPN specialist from the Mount Sinai, New York, shared ins
Originally published by Oncology Brothers. We curate and add context; they did the reporting.
Read the full story at Oncology Brothers ↗